Certified by Founder Lodge
Verismo Therapeutics
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $7,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignanc
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 01 ,2023 | Pre Series A | $7,000,000 | |
| July, 19 ,2023 | Seed | $6,000,000 |
BRV Capital Management
Ignite Innovations
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Zero Homes | $16,800,000 | (Feb 19, 2026)
